Showing results (2591-2600 of 3,512) with videos related to
Sort By:
Pageof 352
Eclinicalmedicine|September 23, 2026
A brief video intervention targeting self-stigma among childhood maltreatment survivors: an international, multicentre, single-blind, randomised controlled trialShilat Haim-Nachum, Misari Oe, Soraya Seedat, et al.Eclinicalmedicine|September 23, 2026
Treatment and outcome of chronic disseminated candidiasis in the era of antifungal prophylaxis: a retrospective multicentre cohort of 111 patientsIlana Reinhold, Isabel Cristina Ramirez-Sanchez, Pao-Yu Chen, et al.Eclinicalmedicine|June 2, 2025
Community engagement and chronic viral hepatitis public health interventions: a systematic review, meta-analysis, and complementary crowdsourcing open callYifan Li, Eneyi Kpokiri, Dalia Elasi, et al.Eclinicalmedicine|September 12, 2026
Efficacy and safety of liposomal irinotecan plus nimotuzumab in immune checkpoint inhibitor-refractory recurrent or metastatic nasopharyngeal carcinoma: a single-arm, open-label, phase II trialShuiqing He, Wei-Xin Bei, Nian Lu, et al.Eclinicalmedicine|September 14, 2026
Long-acting HIV pre-exposure prophylaxis adherence and discontinuation: a global systematic review and meta-analysisXinyue Feng, Xinsheng Wu, Thomas S Fitzpatrick, et al.Eclinicalmedicine|September 14, 2026
Pediatric yeast fungaemia species patterns, resistance profiles, and outcomes: a 20-year surveillance study in Paris, FranceFanny Alby-Laurent, Thomas Obadia, Maud Gits-Muselli, et al.Eclinicalmedicine|September 14, 2026
Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trialJames Russell Pike, Alison R Huang, Nicholas Reed, et al.Eclinicalmedicine|August 26, 2026
Pancreatic enzymes and bile acids alone and in combination for acutely ill, severely malnourished children: a multi-country double-blind randomised placebo-controlled trialRobert H J Bandsma, Mohammod Jobayer Chisti, Wieger P Voskuijl, et al.Eclinicalmedicine|October 10, 2026
Safety and efficacy of SOM3355 in patients with Huntington's disease (SOMCT03): a phase 2b, randomised, placebo-controlled, multicentre, dose-ranging studyJaime Kulisevsky, David Craufurd, Jan Lewerenz, et al.Eclinicalmedicine|October 10, 2026
Comorbid insomnia and sleep apnea (COMISA) and incident cardiovascular risk: a prospective analysis from the HypnoLaus cohortGeoffroy Solelhac, Théo Imler, Nicola-Andrea Marchi, et al.Pageof 352